BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7478555)

  • 1. Malignant transformation of rat embryo fibroblasts by cotransfection with eleven human mutant p53 cDNAs and activated H-ras gene.
    Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Konishi M; Kawashima I; Takamoto S; Hirai H; Miyaki M
    Oncogene; 1995 Oct; 11(7):1339-45. PubMed ID: 7478555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras.
    Bristow RG; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
    Oncogene; 1994 Jun; 9(6):1527-36. PubMed ID: 8183546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
    Hinds PW; Finlay CA; Quartin RS; Baker SJ; Fearon ER; Vogelstein B; Levine AJ
    Cell Growth Differ; 1990 Dec; 1(12):571-80. PubMed ID: 2288874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B.
    Yam JW; Chan KW; Hsiao WL
    Oncogene; 2001 Jan; 20(1):58-68. PubMed ID: 11244504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear localization is essential for the activity of p53 protein.
    Shaulsky G; Goldfinger N; Tosky MS; Levine AJ; Rotter V
    Oncogene; 1991 Nov; 6(11):2055-65. PubMed ID: 1719467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for synergistic interactions between ras, myc and a mutant form of p53 in cellular transformation and tumor dissemination.
    Taylor WR; Egan SE; Mowat M; Greenberg AH; Wright JA
    Oncogene; 1992 Jul; 7(7):1383-90. PubMed ID: 1620551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135).
    Yam JW; Zheng JY; Hsiao WL
    Biochem Biophys Res Commun; 1999 Dec; 266(2):472-80. PubMed ID: 10600527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism between pairs of immortalizing genes in transformation assays of rat embryo fibroblasts.
    Peacock JW; Matlashewski GJ; Benchimol S
    Oncogene; 1990 Dec; 5(12):1769-74. PubMed ID: 2178238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
    Woo RA; Poon RY
    Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The properties of p53 proteins selected for the loss of suppression of transformation.
    Olson DC; Levine AJ
    Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the transformed and neoplastic phenotype of rat fibroblasts by MHC-I gene expression.
    Gattoni-Celli S; Strauss RM; Willett CG; Pozzatti R; Isselbacher KJ
    Cancer Res; 1989 Jun; 49(12):3392-5. PubMed ID: 2655894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H; Lai B; Li J
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming activity of mutant human p53 alleles.
    Slingerland JM; Benchimol S
    J Cell Physiol; 1991 Sep; 148(3):391-5. PubMed ID: 1918170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.
    Du Villard JA; Wicker R; Crespo P; Russo D; Filetti S; Gutkind JS; Sarasin A; Suárez HG
    Oncogene; 2000 Oct; 19(42):4896-905. PubMed ID: 11039907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
    Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
    Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gene for the rat heat-shock cognate, hsc70, can suppress oncogene-mediated transformation.
    Yehiely F; Oren M
    Cell Growth Differ; 1992 Nov; 3(11):803-9. PubMed ID: 1467307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutations and tetraploids under r- and K-selection.
    Chikatsu N; Nakamura Y; Sato H; Fujita T; Asano S; Motokura T
    Oncogene; 2002 May; 21(19):3043-9. PubMed ID: 12082535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of normal human p53 in established fibroblasts leads to their tumorigenic conversion.
    Tuck SP; Crawford L
    Oncogene Res; 1989; 4(2):81-96. PubMed ID: 2654816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.